CommSec's Tom Piotrowski speaks with AirXpanders (AXP) CEO, Scott Dodson about: Show More
Airxpanders
Tom Piotrowski speaks with AirXpanders (AXP) CEO & President, Scott Dodson about the company’s performance since listing on the ASX 18 months ago & its recently received FDA approval for its AeroForm product To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series.html Show More
Some of the greatest healthcare plays I know involve a new product that is not only safe and effective but replace a current treatment modality best described as 'brutal'. AirXpanders (ASX: AXP), a >A$270m company which went public on ASX in 2015, is a great example. This company's AeroForm technology... Show More
Steven Daghlian speaks with AirXpanders Inc (AXP) CEO Scott Dodson about the company’s AeroForm product, its recent share price growth and plans for growth in the United States To view more Executive Series interviews, visit: https://www.commsec.com.au/market-news/executive-series.html Show More
Medtech companies have seen continued strength since our report on the sector last month, which you can see here: https://www.livewiremarkets.com/wires/27927. There is continued speculation on increasing M&A in the sector, with Australia reportedly on the radar of US players. Canaccord IPO'd medtech company 'AirXpanders' into a receptive market in mid-June,... Show More